Anne Marie Bak Jylling

PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor–Positive Early Breast Cancer

Anne‐Vibeke Lænkholm, Maj‐Britt Jensen, Jens Ole Eriksen et al. · Journal of Clinical Oncology · 2018 · 188 citations

Medicine, Endocrinology, Oncology +17

Population-based risk estimates of Wilms tumor in sporadic aniridia

Karen Grønskov, Jørgen H. Olsen, Annie Sand et al. · Human Genetics · 2001 · 139 citations

Medicine, Oncology, Pathology +13

[¹⁸F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy

Malene Grubbe Hildebrandt, Oke Gerke, Christina Baun et al. · Journal of Clinical Oncology · 2016 · 88 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Correlation between circulating cell‐free <i><scp>PIK</scp>3<scp>CA</scp></i> tumor <scp>DNA</scp> levels and treatment response in patients with <i><scp>PIK</scp>3<scp>CA</scp></i>‐mutated metastatic breast cancer

Annette Raskov Kodahl, Sidse Ehmsen, Niels Pallisgaard et al. · Molecular Oncology · 2018 · 71 citations · Full text

Medicine, Molecular Biology, Oncology +17

An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG)

Anne‐Vibeke Lænkholm, Dorthe Grabau, Maj‐Lis Møller Talman et al. · Acta Oncologica · 2017 · 44 citations · Full text

Medicine, Oncology, Pathology +15